References
Ballantyne FC, Fleck A, Dick C. Albumin metabolism in rheumatoid arthritis. Annals of the Rheumatic Diseases 30: 265–270, 1971
Baum J, Ziff M. Laboratory findings in rheumatoid arthritis. In Mc Carty DJ. Arthritis and allied conditions, pp. 643–659, Lea & Febiger, Philadelphia 1985
Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 9: 326–363, 1975
Day RO, Furst DE, Dromgoole SH, Kamm B, Roe R, et al. Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clinical Pharmacology and Therapeutics 31: 733–740, 1982
Gottlieb N, Smith PM, Smith EM. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Arthritis and Rheumatism 17: 171–183, 1974
Reidenberg MM, Drayer DE. Alteration of drug-protein binding in renal disease. Clinical Pharmacokinetics 9 (Suppl. 1): 18–26, 1984
Runkel R, Chaplin M, Sevelius H, Ortega E, Segre E. Pharmacokinetics of naproxen overdoses. Clinical Pharmacology and Therapeutics 20: 269–277, 1976
Scatchard G. The attractions of proteins for small molecules and ions. Annals of the New York Academy of Science 51: 660–672, 1949
Selley ML, Madsen BW, Thomas J. Protein binding of tolmetin. Clinical Pharmacology and Therapeutics 24: 694–705, 1978
Upton RA, Buskin JN, Williams RL, Holford NHG, Riegelman S. Negligible excretion of unchanged ketoprofen, naproxen and probenecid in urine. Journal of Pharmaceutical Sciences 69: 1254–1257, 1980
Van Loenhout JWA, Van Ginneken CAM, Ketelaars HCJ, Kimenai PM, Tan Y, et al. A high-performance liquid Chromatographic method for the quantitative determination of naproxen and des-methyl-naproxen in biological samples. Journal of Liquid Chromatography 5: 549–561, 1982
Van Riel PLMC, Gribnau FWJ, Van De Putte LBA. Cell-bound gold in patients treated with aurothioglucose and auranofin. Journal of Rheumatology 10: 574–578, 1983
Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clinical Pharmacokinetics 8: 297–331, 1983
Wanwimolruk S, Birkett DJ, Brooks PM. Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clinical Pharmacokinetics 7: 85–92, 1982
Wilkinson P, Jeremy R, Brooks FP, Hollander JL. The mechanism of hypoalbuminaemia in rheumatoid arthritis. Annals of Internal Medicine 63: 109–114, 1965
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Den Ouweland, F.A., Gribnau, F.W.J., Tan, Y. et al. Hypoalbuminaemia and Naproxen Pharmacokinetics in a Patient with Rheumatoid Arthritis. Clin-Pharmacokinet 11, 511–515 (1986). https://doi.org/10.2165/00003088-198611060-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198611060-00007